Genomics Market

Executive Summary

Genomics Market was valued at US $33.99 billion in 2021 and is projected to grow at 21.84% CAGR over the forecast period to reach US $111.22 billion by 2027. Genomics Market represented US $11.10 billion opportunity over 2019-2021 and estimated to create US $77.23 billion opportunity in 2027 over 2021.

Genomics from Consainsights analyses the Genomics Market in the Life Sciences industry over the forecast period to 2027.

Genomics research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Genomics segmentation includes Product & Service, Technology, Application, End-user, Region and Geography.

Based on the Product & Service, the Genomics analysis covers Consumables, Systems & Software, Services.

In Product & Service segment, Consumables segment has highest cagr growth of 19.20%.

Based on the Technology, the Genomics analysis covers Sequencing, PCR, Nucleic Acid Extraction and Purification, Microarrays, Other Technologies.

In Technology segment, Sequencing segment has highest cagr growth of 19.20%.

Based on the Application, the Genomics analysis covers Drug Discovery and Development, Diagnostics, Agriculture and Animal Research, Other Applications.

In Application segment, Drug Discovery and Development segment has highest cagr growth of 19.20%.

Based on the End-user, the Genomics analysis covers Hospitals & Clinics, Research Centers and Academic & Government Institutes, Pharmaceutical & Biotechnology Companies, Other End-users.

In End-user segment, Hospitals & Clinics segment has highest cagr growth of 19.20%.

Based on the Region, the Genomics analysis covers North America, Europe, Asia-Pacific, Rest of the World.

In Region segment, North America segment has highest cagr growth of 19.20%.

Based on the region, the Genomics analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Major Players and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product & Service

Introduction

In 2021, Consumables segment has the highest revenue of US $13.06 billion and is expected to grow at CAGR of 19.20% by 2027 Consumables segment has highest cagr growth of 19.20%.

Consumables

Consumables segment was valued at US $8.80 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $42.74 billion by 2027. Consumables segment represented US $4.26 billion opportunity over 2019-2021 and estimated to create US $29.68 billion opportunity in 2027 over 2021.

Systems & Software

Systems & Software segment was valued at US $8.16 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $39.63 billion by 2027. Systems & Software segment represented US $3.95 billion opportunity over 2019-2021 and estimated to create US $27.52 billion opportunity in 2027 over 2021.

Services

Services segment was valued at US $5.94 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $28.84 billion by 2027. Services segment represented US $2.88 billion opportunity over 2019-2021 and estimated to create US $20.03 billion opportunity in 2027 over 2021.

Technology

Introduction

In 2021, Sequencing segment has the highest revenue of US $13.70 billion and is expected to grow at CAGR of 19.20% by 2027 Sequencing segment has highest cagr growth of 19.20%.

Sequencing

Sequencing segment was valued at US $9.23 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $44.81 billion by 2027. Sequencing segment represented US $4.47 billion opportunity over 2019-2021 and estimated to create US $31.12 billion opportunity in 2027 over 2021.

PCR

PCR segment was valued at US $7.60 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $36.90 billion by 2027. PCR segment represented US $3.68 billion opportunity over 2019-2021 and estimated to create US $25.62 billion opportunity in 2027 over 2021.

Nucleic Acid Extraction and Purification

Nucleic Acid Extraction and Purification segment was valued at US $2.85 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $13.85 billion by 2027. Nucleic Acid Extraction and Purification segment represented US $1.38 billion opportunity over 2019-2021 and estimated to create US $9.62 billion opportunity in 2027 over 2021.

Microarrays

Microarrays segment was valued at US $1.49 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $7.26 billion by 2027. Microarrays segment represented US $0.72 billion opportunity over 2019-2021 and estimated to create US $5.04 billion opportunity in 2027 over 2021.

Other Technologies

Other Technologies segment was valued at US $1.73 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $8.39 billion by 2027. Other Technologies segment represented US $0.84 billion opportunity over 2019-2021 and estimated to create US $5.83 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Drug Discovery and Development segment has the highest revenue of US $16.15 billion and is expected to grow at CAGR of 19.20% by 2027 Drug Discovery and Development segment has highest cagr growth of 19.20%.

Drug Discovery and Development

Drug Discovery and Development segment was valued at US $10.88 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $52.84 billion by 2027. Drug Discovery and Development segment represented US $5.27 billion opportunity over 2019-2021 and estimated to create US $36.69 billion opportunity in 2027 over 2021.

Diagnostics

Diagnostics segment was valued at US $6.80 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $33.05 billion by 2027. Diagnostics segment represented US $3.30 billion opportunity over 2019-2021 and estimated to create US $22.95 billion opportunity in 2027 over 2021.

Agriculture and Animal Research

Agriculture and Animal Research segment was valued at US $4.70 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $22.81 billion by 2027. Agriculture and Animal Research segment represented US $2.28 billion opportunity over 2019-2021 and estimated to create US $15.84 billion opportunity in 2027 over 2021.

Other Applications

Other Applications segment was valued at US $0.52 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $2.52 billion by 2027. Other Applications segment represented US $0.25 billion opportunity over 2019-2021 and estimated to create US $1.75 billion opportunity in 2027 over 2021.

End-user

Introduction

In 2021, Hospitals & Clinics segment has the highest revenue of US $15.02 billion and is expected to grow at CAGR of 19.20% by 2027 Hospitals & Clinics segment has highest cagr growth of 19.20%.

Hospitals & Clinics

Hospitals & Clinics segment was valued at US $10.12 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $49.15 billion by 2027. Hospitals & Clinics segment represented US $4.90 billion opportunity over 2019-2021 and estimated to create US $34.13 billion opportunity in 2027 over 2021.

Research Centers and Academic & Government Institutes

Research Centers and Academic & Government Institutes segment was valued at US $6.55 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $31.80 billion by 2027. Research Centers and Academic & Government Institutes segment represented US $3.17 billion opportunity over 2019-2021 and estimated to create US $22.08 billion opportunity in 2027 over 2021.

Pharmaceutical & Biotechnology Companies

Pharmaceutical & Biotechnology Companies segment was valued at US $3.65 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $17.73 billion by 2027. Pharmaceutical & Biotechnology Companies segment represented US $1.77 billion opportunity over 2019-2021 and estimated to create US $12.31 billion opportunity in 2027 over 2021.

Other End-users

Other End-users segment was valued at US $2.58 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $12.54 billion by 2027. Other End-users segment represented US $1.25 billion opportunity over 2019-2021 and estimated to create US $8.71 billion opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $16.26 billion and is expected to grow at CAGR of 19.20% by 2027 North America segment has highest cagr growth of 19.20%.

North America

North America segment was valued at US $10.95 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $53.19 billion by 2027. North America segment represented US $5.31 billion opportunity over 2019-2021 and estimated to create US $36.93 billion opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $6.55 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $31.79 billion by 2027. Europe segment represented US $3.17 billion opportunity over 2019-2021 and estimated to create US $22.08 billion opportunity in 2027 over 2021.

Asia-Pacific

Asia-Pacific segment was valued at US $4.64 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $22.54 billion by 2027. Asia-Pacific segment represented US $2.25 billion opportunity over 2019-2021 and estimated to create US $15.65 billion opportunity in 2027 over 2021.

Rest of the World

Rest of the World segment was valued at US $0.76 billion in 2019 and is projected to grow at 19.20% CAGR over the forecast period to reach US $3.69 billion by 2027. Rest of the World segment represented US $0.37 billion opportunity over 2019-2021 and estimated to create US $2.56 billion opportunity in 2027 over 2021.